Myostatin deficiency protects C2C12 cells from oxidative stress by inhibiting intrinsic activation of apoptosis
- Ischemia reperfusion (IR) injury remains an important topic in clinical medicine. While a multitude of prophylactic and therapeutic strategies have been proposed, recent studies have illuminated protective effects of myostatin inhibition. This study aims to elaborate on the intracellular pathways involved in myostatin signaling and to explore key proteins that convey protective effects in IR injury. We used CRISPR/Cas9 gene editing to introduce a myostatin \(\textit {(Mstn)}\) deletion into a C2C12 cell line. In subsequent experiments, we evaluated overall cell death, activation of apoptotic pathways, ROS generation, lipid peroxidation, intracellular signaling via mitogen-activated protein kinases (MAPKs), cell migration, and cell proliferation under hypoxic conditions followed by reoxygenation to simulate an IR situation in vitro (hypoxia reoxygenation). It was found that mitogen-activated protein kinase kinase 3/6, also known as MAPK/ERK Kinase 3/6 (MEK3/6), and subsequent p38 MAPK activation were blunted in C2C12-\(it Mstn^{−/−}\) cells in response to hypoxia reoxygenation (HR). Similarly, c-Jun N-terminal kinase (JNK) activation was negated. We also found the intrinsic activation of apoptosis to be more important in comparison with the extrinsic activation. Additionally, intercepting myostatin signaling mitigated apoptosis activation. Ultimately, this research validated protective effects of myostatin inhibition in HR and identified potential mediators worth further investigation. Intercepting myostatin signaling did not inhibit ROS generation overall but mitigated cellular injury. In particular, intrinsic activation of apoptosis origination from mitochondria was alleviated. This was presumably mediated by decreased activation of p38 caused by the diminished kinase activity increase of MEK3/6. Overall, this work provides important insights into HR signaling in C2C12-\(it Mstn^{−/−}\) cells and could serve as basis for further research.
Author: | Marius DryschORCiDGND, Sonja Verena SchmidtGND, Mustafa BecerikliORCiDGND, Felix ReinkemeierGND, Stephanie DittfeldGND, Johannes Maximilian WagnerORCiDGND, Mehran DadrasORCiDGND, Alexander Klaus SogorskiORCiDGND, Maxi SacherORCiDGND, Marcus LehnhardtGND, Björn BehrORCiDGND, Christoph WallnerGND |
---|---|
URN: | urn:nbn:de:hbz:294-84567 |
DOI: | https://doi.org/10.3390/cells10071680 |
Parent Title (English): | Cells |
Publisher: | MDPI |
Place of publication: | Basel |
Document Type: | Article |
Language: | English |
Date of Publication (online): | 2021/12/08 |
Date of first Publication: | 2021/07/03 |
Publishing Institution: | Ruhr-Universität Bochum, Universitätsbibliothek |
Tag: | Open Access Fonds GDF8; hypoxia; ischemia; muscle; myostatin; reoxygenation; reperfusion; skeletal |
Volume: | 10 |
Issue: | 7, Article 1680 |
First Page: | 1680-1 |
Last Page: | 1680-14 |
Note: | Article Processing Charge funded by the Open Access Publication Fund of Ruhr-Universität Bochum. |
Institutes/Facilities: | Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Klinik für Plastische Chirurgie und Schwerbrandverletzte |
Dewey Decimal Classification: | Technik, Medizin, angewandte Wissenschaften / Medizin, Gesundheit |
open_access (DINI-Set): | open_access |
Licence (English): | Creative Commons - CC BY 4.0 - Attribution 4.0 International |